Clinical trials: Tamsulosin
Benign Prostatic Hyperplasia, Erectile Dysfunction
The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
The efficacy and safety of the combination of tamsulosin and tadalafil in men with lower urinary tract symptoms due to benign prostatic hyperplasia and Erectile Dysfunction: a randomized, double blinded, parallel design, active…
- Trial name
- NCT02862483
- Testing
- Tamsulosin 0.2mg, Tadalafil 5mg
- Where
- South Korea
- Volunteers
- 330 people
- Sponsor
- IlDong Pharmaceutical Co Ltd
Lower Urinary Tract Symptoms
Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent Irritation
The objective of this project is to compare the efficacy of hyoscyamine to tamsulosin monotherapy in treating lower urinary tract symptoms in patients with indwelling double-J ureteral stents.
- Trial name
- HyTa Stent (NCT03750656)
- Testing
- Hyoscyamine, Tamsulosin
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- University of Kansas Medical Center
Prostatic Hyperplasia
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin
It will be an open-label, randomized, laboratory-blind, crossover study with 02 treatments, 02 sequences, and 02 periods, in which the volunteers receive, in each period, the test formulation or the reference formulation, under…
- Trial name
- NCT01330303
- Testing
- Reference formulation, Test formulation
- Where
- Brazil
- Volunteers
- 37 people, healthy volunteers welcome
- Sponsor
- GlaxoSmithKline
Benign Prostatic Hyperplasia, Overactive Bladder
A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
The purpose of the study was to assess the efficacy, safety, and tolerability of mirabegron versus placebo in men with overactive bladder (OAB) symptoms while taking tamsulosin hydrochloride for lower urinary tract symptoms…
- Trial name
- PLUS (NCT02757768)
- Testing
- Mirabegron, Tamsulosin Hydrochloride
- Where
- 79 sites in United States, Canada and 7 more
- Volunteers
- 715 people
- Sponsor
- Astellas Pharma Global Development, Inc.
Urinary Catheterization, Thoracic Surgery
REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial
The purpose of this study are to determine the efficacy of tamsulosin compared to placebo in reducing post-operative urinary retention and improving other clinical outcomes in people undergoing thoracic surgery.
- Conditions
- Urinary Catheterization, Thoracic Surgery, Thoracic Epidural Analgesia
- Trial name
- REPOURT-P (NCT04159077)
- Testing
- Tamsulosin Hydrochloride
- Volunteers
- 350 people
- Sponsor
- McMaster University
BPH With Urinary Obstruction
Early Versus Late Catheter Removal in Patients With Acute Urinary Retention Secondary to BPH Under Tamsulosin Treatment
The aim of this work is to compare between early (3days) and late(7days) removal of urinary catheter after acute urine retention in patients with Benign Prostatic Hyperplasia under Tamsulosin treatment.
- Trial name
- NCT03280420
- Testing
- Early catheter removal, Late catheter removal
- Where
- Egypt
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Salem Hassan Salem Mohamed
Ureteric Stone of Lower Third of Ureter
Medical Stone Expulsive Therapy for Acutely Obstructed Ureteric Calculi
As a first treatment option for small-size ureteric stones, α-blockers are now being used for medical expulsive therapy (MET) instead of invasive procedures.
- Trial name
- NCT05977647
- Testing
- Tamsulosin Oral Capsule
- Where
- Pakistan
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- Getz Pharma
Overactive Bladder
A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks
The purpose of this study is to evaluate the rate of "add-on" solifenacin treatment and its persistency in men with over active bladder symptoms after tamsulosin monotherapy for 4 weeks.
- Trial name
- NCT00884104
- Testing
- Solifenacin
- Where
- 9 sites in South Korea
- Volunteers
- 307 people
- Sponsor
- KYU-SUNG LEE